在医院管理年中加强行风建设探讨

文章阐述了吉林省肿瘤医院多年来加强行风建设工作取得的成绩和体会,就如何结合卫生部"医院管理年"活动的要求,进一步加强行风建设,创建"医院诚信体系",严格规范医疗行为,不断提高医院管理水平进行了探讨.     

加强行业作风建设促进医院健康发展

文章主要介绍了河南省肿瘤医院在治理药品临床促销,实行患者住院费用"一日清单"制,开展社会服务承诺和行风建设目标责任制等行业作风建设方面的做法,和做好纠风工作的体会.     

CT室房屋布局和建设的体会

总结辽宁省肿瘤医院CT室布局和建设的体会.     

护理部在护理模式变革中的职能作用

在护理模式变革中 ,护理管理者如何站在学科发展前沿 ,把握好变革方向 ,不断开拓护理工作中的新领域 ,以适应社会发展和病人的需求 ,是当前护理管理者面临的新课题。为此 ,我院在组织实施整体护理模式的过程中 ,充分发挥护理管理在医院管理系统中相对独立的职能作用 ,使以病人为中心的护理模式在我院顺利开展并落到实处。结合工作实践 ,总结报告如下。1　转变思想观念 ,树立全新的护理模式观是前提任何一项变革的实施首先需要管理人员转变思想观念 ,从全新的角度认识护理基本概念、人的健康概念及与新护理模式的关系 ,从整体护理入手研究护…     

加强肿瘤专科医院管理

过去的五年，是我国建国以来卫生事业发展速度最快的时期．医疗卫生服务规模、服务条件、服务水平都有了很大改善和提高。进入2006年．新的五年规划开始实施。“十一五”期间将是我国发展的关键时期．医院发展既面临良好的机遇，也将面对诸多社会矛盾。     

浅谈护理管理中护士的价值体现

护理管理是以提高护理质量为主要目的的工作过程 ,是控制护理质量的重要措施。提供高品质护理服务的过程 ,就是体现护理专业价值的过程 ,即护理人员的价值定位。在现代医院护理管理中 ,护士的价值体现在以下几个方面。1　服务态度护理服务价值的核心是态度 ,护士以怎样的态度对     

天津肿瘤医院人才梯队建设现状

全文介绍天津医科大学附属肿瘤医院实施"创新团队建设工程",开展人才梯队可持续发展的培养和支持体系.     

Life Style Management in Head and Neck Cancer Patients

Head and neck (HN) cancers involve highly visible body parts, structurally complex, and crucial to survival. A diagnosis of HN cancer, like any cancer diagnosis, is often accompanied by much fear and uncertainty. In addition, patients treated for HN cancer face difficulties in eating, chewing, drinking, breathing, speaking, as well as changes in appearance. Simultaneously, the burden of HN cancer is often manifested in psychosocial dysfunction, which can have a negative impact on quality of life (QL). Psychosocial interventions such as education along with cognitive-behavioral therapy generally provide an overall positive effect. With the growing impetus to investigate factors associated with these dysfunctions and disfigurement caused by the treatment, and considerable advancement in the development and validation of many global and disease-specific measures, there is an opportunity for further research to develop an appropriate clinical intervention program for such patients so that these patients can live a near normal life. Life style changes including dietary habits make gross changes in QL.     

肿瘤化疗病房的护理管理

全文主要就肿瘤化疗病房护理人员专科知识的培训，自身的防护，化疗药物的管理，废物处理。病人的管理等进行阐述。     

肺癌治疗的新靶点及应用前景

近年来分子生物学技术不断进步．涌现出许多肺癌治疗的新靶点和针对这些新靶点的新药物。文章从细胞信号传导通路、细胞生存途径、基因治疗及血管生成四方面简要介绍这些新靶点和已经或正在研发的新药物。     

New Perspective for Integrated Information Management in National Colorectal Cancer Screening in Iran

Colorectal cancer screening management, especially for those with a genetic predisposition, depends onadequate and standard reporting. Standardized reporting systems for diagnostic and screening tests facilitatequality improvement of programs and clear communication among health care providers. This article presentsa comprehensive picture of the information content of colorectal cancer screening in the national plan of Iran,consisting of demographic and medical findings and other standard reports (colonoscopy, pathology, geneticsand pedigree data). In addition this review presents data flow in screening and data elements in patientperspectives on colorectal cancer screening.     

癌症诊疗中医患沟通问题探讨

癌症患者在诊疗前后都不同程度地受到不正确认知的困扰.重视患者诊疗中医患沟通问题,对解除这些困扰,提高患者生活质量至关重要.文章主要对癌症诊疗中医患沟通问题进行探讨.     

New Approaches in the Management of Male Breast Cancer

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our current evidence base for treatment is derived from female breast cancer (FBC) patients. Risk factors for MBC include age, genetic predisposition, race, sex hormone exposure, and environmental factors. Most patients present later and with more advanced disease than comparable FBC patients. Tumors are likely to be estrogen receptor and progesterone receptor positive, with the most common histologic type being invasive ductal carcinoma. Triple assessment remains the criterion standard for diagnosis. Primary MBC is mostly managed initially by simple mastectomy, with the option of breast conserving surgery, which carries an increased risk of recurrence. Sentinel node biopsy is recommended as the initial procedure for staging the axilla. Reconstructive surgery focuses on achieving primary skin closure, and radiotherapy largely follows treatment protocols validated in FBC. We recommend chemotherapy for men with more advanced disease, in particular, those with estrogen receptor negative histology. MBC responds well to endocrine therapy, although it is associated with significant adverse effects. Third-generation aromatase inhibitors are promising but raise concerns due to their failure to prevent estrogen synthesis in the testes. Fulvestrant remains unproven as a therapy, and data on trastuzumab is equivocal with HER2 receptor expression and functionality unclear in MBC. In metastatic disease, drug-based hormonal manipulation remains a first-line therapy, followed by systemic chemotherapy for hormone-refractory disease. Prognosis for MBC has improved over the past 30 years, with survival affected by disease staging, histologic classification, and comorbidity.